Back to top

The Zacks Analyst Blog Highlights: Eli Lilly, HSBC, Marriott, American Airlines and Humana

Read MoreHide Full Article

For Immediate Release

Chicago, IL – June 01, 2017 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Eli Lilly (LLY - Free Report) – Free Report), HSBC (HSBC - Free Report) – Free Report), Marriott (MAR - Free Report) – Free Report), American Airlines (AAL - Free Report) – Free Report) and Humana (HUM - Free Report) – Free Report).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Wednesday’s Analyst Blog:

Top Stock Reports for Today: LLY, HSBC, MAR & More

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly ( (LLY - Free Report) – Free Report ), HSBC (HSBC - Free Report) – Free Report) and Marriott (MAR - Free Report) – Free Report). You can see all of today’s research reports here >>>

Pharmaceutical stocks have been under pressure since last year on pricing and regulatory concerns and Eli Lilly shares have been no different. That said, the stock has done modestly better than the peer group; it is up +5.7% over the last 12 months vs. +1.7% gain for the Zacks Pharma industry and -0.7% decline for the Zacks Medical sector as a whole. Lilly’s recent high-profile pipeline setbacks are a concern for investors. But the Zacks analyst is encouraged by the fact that Lilly expects to launch 20 new products in a 10 year time-frame ranging from 2014 to 2023 and could launch at least 2 new indications/line extensions on average every year. Moreover, Lilly returned to annual dividend hikes in Dec 2016 and plans to return excess cash through share buybacks. (You can read the full research report on Eli Lily here >>>.

Shares of Buy rated HSBC outperformed the Zacks Foreign Banks industry over the last three months, gaining +7.3% vs -1.7%. The Zacks analyst likes its extensive global network, strong capital position and a solid asset growth. Moreover, continued disposal of unprofitable/non-core operations has enhanced its efficiency, as operating costs remain manageable. Further, the company remains on track to achieve its 2017 cost savings target. However, operating uncertainty in the post-Brexit Europe remains a major cloud on the bank as are recent muted trends in loan demand. (You can read the full research report on HSBC here >>>.

Marriott ’s shares have outperformed the Zacks Hotels industry in the year-to-date period (the stock is up +28.9% vs. +3.9% gain for the industry). With the purchase of Starwood, Buy-rated Marriott became the world’s largest hotel company that provides it with increased scale and a robust development pipeline. The Zacks analyst likes Marriott’s rising North American business and large international exposure and thinks they should continue to drive growth. Further, investments in technology for hotel bookings are likely to improve guest experience and thus boost occupancy. Yet, political uncertainties in key international markets and currency headwinds remain causes of concern. (You can read the full research report on Marriott here >>> .

Other noteworthy reports we are featuring today include American Airlines ( (AAL - Free Report) – Free Report ) and Humana (HUM - Free Report) – Free Report ).

Now See All Our Private Trades

While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>

Get the full Report on LLY - FREE

Get the full Report on HSBC – FREE

Get the full Report on MAR - FREE

Get the full Report on AAL - FREE

Get the full Report on HUM - FREE

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

More from Zacks Press Releases

You May Like